[(2,4,6-Triisopropyl-phenyl)-acetyl]-phosphoramidic acid 2,6-diisopropyl-phenyl ester methyl ester

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 英文名称: [(2,4,6-Triisopropyl-phenyl)-acetyl]-phosphoramidic acid 2,6-diisopropyl-phenyl ester methyl ester
• 英文别名: [2-(2,4,6-Triisopropyl-phenyl)-acetyl]-phosphoramidic acid 2,6-diisopropyl-phenyl ester methyl ester；N-[[2,6-di(propan-2-yl)phenoxy]-methoxyphosphoryl]-2-[2,4,6-tri(propan-2-yl)phenyl]acetamide
• 化学式: C₃₀H₄₆NO₄P
• 分子量: 515.673
• InChiKey: QTFIQNRPNXCKLC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  8
• 重原子数：
  36
• 可旋转键数：
  11
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.57
• 拓扑面积：
  64.6
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  丙泊酚 在 ammonium hydroxide 、 sodium hydride 作用下， 以 四氢呋喃 为溶剂， 生成 [(2,4,6-Triisopropyl-phenyl)-acetyl]-phosphoramidic acid 2,6-diisopropyl-phenyl ester methyl ester
  参考文献：
  名称：

  Inhibitors of Acyl-CoA:Cholesterol O-acyltransferase (ACAT) as hypocholesterolemic agents: Synthesis and structure-activity relationships of novel series of sulfonamides, acylphosphonamides and acylphosphoramidates

  摘要：

  Sulfoacetic acid, phosphoramidate, and phosphonamide analogs of the ACAT inhibitors, CI-999 and CI-1011 were synthesized. The structure-activity relationships of these compounds as ACAT inhibitors are described. (C) 1998 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(98)00011-0

文献信息

• Phosphonamide ACAT inhibitors
  申请人：Warner-Lambert Company

  公开号：US05807846A1

  公开（公告）日：1998-09-15

  The present invention is directed to compounds useful for the regulation of cholesterol of Formula I, methods for using them and pharmaceutical compositions thereof, ##STR1## wherein Ar and Ar.sup.1 are each independently selected from unsubstituted or substituted phenyl which substituents are from 1-5 in number and are each independently selected from alkyl, alkoxy, hydroxy, halogen, nitro, trifluoromethyl, COOH, and COOalkyl; X is --NH--, --O--, --S--, or --(CH.sub.2).sub.0-4 --, and R is hydrogen, alkyl, or phenyl.

  本发明涉及一种用于调节胆固醇的化合物，其化学式为I，以及使用它们的方法和药物组合物，其中Ar和Ar.sup.1各自独立地选择自未取代或取代的苯基，所述取代基的数量为1-5，并且各自独立地选择自烷基、烷氧基、羟基、卤素、硝基、三氟甲基、COOH和COO烷基；X为--NH--、--O--、--S--或--(CH.sub.2).sub.0-4 --，R为氢、烷基或苯基。
• US5807846A
  申请人：——

  公开号：US5807846A

  公开（公告）日：1998-09-15
• US6017905A
  申请人：——

  公开号：US6017905A

  公开（公告）日：2000-01-25
• Inhibitors of Acyl-CoA:Cholesterol O-acyltransferase (ACAT) as hypocholesterolemic agents: Synthesis and structure-activity relationships of novel series of sulfonamides, acylphosphonamides and acylphosphoramidates
  作者：H.T Lee、W.H Roark、J.A Picard、D.R Sliskovic、B.D Roth、R.L Stanfield、K.L Hamelehle、R.F Bousley、B.R Krause

  DOI：10.1016/s0960-894x(98)00011-0

  日期：1998.2

  Sulfoacetic acid, phosphoramidate, and phosphonamide analogs of the ACAT inhibitors, CI-999 and CI-1011 were synthesized. The structure-activity relationships of these compounds as ACAT inhibitors are described. (C) 1998 Elsevier Science Ltd. All rights reserved.